Fig. 4From: Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle EastSurvival curves of time to the first MS relapse during the study (Kaplan-Meier plot; FAS). a Fingolimod cohort. b Other DMTs cohort. DMT, disease-modifying treatment; FAS, full analysis set; MS, multiple sclerosis Back to article page